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7. Crofton PM, Smith AF. Alkaline phosphatase of high and low molecular mass in human serum and bile: A comparative study of kinetic properties. Clin Chem 26, 451-456 (1980 Metabolic screening by chromatographic analysis for amino acids and organic acids in blood and urine is now commonly used as a diagnostic test in patients with neurological abnormalities and metabolic acidosis. The most frequent cause of artifacts is medication such as antibiotics (1), mucolytic agents (1), and anticonvulsants (2). Recently, we encountered another drug metabolite that gave a false-positive amino acid screening result.
Acetaminophen has become increasingly popular as a pain reliever. We have oberved a ninhydrin-reactive compound in urine specimens from patients who took this drug before urine collection. This compound migrated to a locationnear dihydroxyphenylalanme (roPA) in the system of two-dimensional separation of amino acids by high voltage electrophoresis at pH 1.6 (6% formic acid) followed by ascending solvent chromatography in butanoll acetic acid/water 
AutomatedDry-FilmMethodfor Phosphorusin SerumEvaluated
To the Editor:
Many methods for measuring inorganic phosphate in serum are based on the reaction of phosphate with molybdate to form a phosphomolybdate complex that subsequently is reduced. Although the absorbance of the unreduced phosphomolybdate complex may be measured at 340 nm (1), such methods require removal of serum protein to prevent large interferences in icteric or hemolyzed samples (2). Variations among these methods arise from the use of different reducing agents and different methods of protein removal (dialysis, ultrafiltration, or precipitation).
I evaluate here a method for measurement of serum phosphorus based on use of multilayer dry-ifim reagents (Ektachem PHOS clinical chemistry slide; Eastman Kodak, Rochester, NY 14650). Phosphate reacts with ammonium molybdate and the complex formed is reduced with p-methylaminophenol sulfate. After incubation, light is reflected off the slide and measured at 680 nm. To evaluate this method, I compared results with those by the manual Selected Method (3), which involves protein precipitation and semidine . HC1 as the reducing agent, and also studied the betweenday precision and stability of calibration.
The dry-ifim slides are used with an Ektachem 400 analyzer (Eastman Kodak Co.), which aspirates about 25 iL of sample, depositing 10 p.L on the spreading layer of the slide. The reagents on the slide are arranged in layers, as in other Ektachem products (e.g., ref.
4).
I calibrated the methods independently by using the serum-based calibrators from Eastman Kodak (14, 51, and 153 mg of phosphorus per liter) or aqueous standards prepared in house (0, 20, 40, 60, 80, 100 mg/L). The quality-control sera were Monitrol ES Level I and ES Level II (Dade, Miami, FL 33152).
The manufacturer claims that absorbance varies linearly with concentration to 130 mg/L, and initially recommended diluting samples of a higher concentration with a 70 g/L albumin solution. I found that samples containing up to 140 mg of phosphorus per liter needed no dilution and that the use of distilled water gave results nearly identical to those from samples diluted with the albumin solution. The manufacturer now recommends that distilled water be used as diluent.
I calibrated the Ektachem 400 analyzer once weekly with freshly prepared calibrators, as recommended.
The small variations of the absolute reflectance densities at each concentration indicate the stability of the system was excellent (CV 1.1%, for 15 calibrations done during 100 days). The manufacturer has recently recommended calibration at 90-day intervals.
Between-day
precision was determined from the first analysis each day of quality-control material. In all, analyses were done on 67 days during a 108-day period. The precision (CV) was Table 1 summarizes the findings for 100 samples from patients for whom a diagnosis was available. Patients with chronic renal failure or on hemodialysis tended to have somewhat higher results by the Ektachem analyzer than by the Selected Method (which chiefly accounts for the slope of 1.03 in the above equation). For samples that appeared moderately to grossly icteric, hemolyzed, or lipemic, none differed by more than 3 mg/L between methods, but all the grossly hemolyzed samples had lower results by the Ektachem Analyzer. The Selected Method reportedly has a positive bias of about 7 mg/L for 5 gIL hemoglobin (3), so the lower results may indicate that the dry-film method is less affected by hemolysis than is the Selected Method.
The overall agreement of results between the two methods was excellent: All results below 60 mg/L differed between methods by no more than 3 mgI L. Of the 37 results above 60 mg/L, six differed by 5 to 7 mg/L, and in all cases results by the Ektachem analyzer were higher. Five of these six were from We have assessed the optimal pH within a narrow pH range, using a large number of plasmas, and have angiotensin I in the samples is accounted for in this procedure. We analyzed duplicate 50-.tL aiiquots of each set by radioimmunoassay for angiotensin I (limit of detection, 5 fmolI5O ML). The logarithms of the PRA values were analyzed by one-way analysis of variance with a three-level hierarchal classification (13) in the order: patient, pH, pH-duplication, RIA-duplication.
The mean logarithms
of the PRA determinations at the five pH values were 2.782, 2.792, 2.807, 2.814, and 2.807, respectively (SD ranging from 0.561 to 0.576). The highest mean activity was obtained at pH 5.85, which was the optimal pH for about half the samples.
The degree of kurtosis and skewness in the pH groups was not significant. Table 1 shows the analysis of variance of the five pH values. Because 90% of the plasmas had an opti-
